- Corporate Musculoskeletal Programs
GOES RIGHT HERE
Kiio is a digital therapeutics company changing the care delivery paradigm for musculoskeletal pain. Evidence-based, completely scalable, personalized, and consumer-centric, Kiio for Low Back Pain achieves health and economic benefits for employers, health plans, and their members.
Kiio is clinically proven to reduce pain and improve function. We have also completed claims-data based longitudinal studies with partners demonstrating significant reduction in opioids and other prescription medications, Urgent Care/ED, aggressive diagnostics and treatments, and medical spend.
Kiio will be rolling out additional digital therapeutic products covering the remainder of common MSK conditions.
Kiio for Low Back Pain is an end-to-end digital solution – including member awareness, screening and Care Path Optimization, care delivery, and reporting and data analysis. The program is scalable, high value, and customizable to integrate with other in-network solutions.
Kiio includes a customized multi-channel, multi-touch dynamic communication journey to drive awareness and engagement in your population.
After registering, your member completes a brief computer-adaptive online screening, resulting in determination of a multi-dimensional risk profile, and immediate access or referral to appropriate care via Kiio’s Care Path Optimization. For over 80% of members, that means immediate access to their individualized digital care program. For members for whom we identify high medical or behavioral health risk, Kiio can provide immediate referral to in-network care.
Members are then guided through an individualized care program which includes exercise, education and behavior modification, interactive digital coaching, and access to professional care management. Artificial intelligence progresses each member at their own pace and provides exception-based alerting to care management.
Every member response and interaction with the digital program is captured. Kiio provides robust reporting on participation and outcomes, as well as population insights and claims data analysis to examine impact on medical utilization and spend.